BRITISH JOURNAL OF CANCER-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2139001, encodeId=cb7a213900173, content=收回顾性文章吗......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Thu May 25 15:37:45 CST 2023, time=2023-05-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2102172, encodeId=288621021e22a, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤药理 经验分享：太太太太慢了，一审半年，补实验两个月，又等了四个月，最后拒稿！慎投！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3f785469539, createdName=ms2000001925534900, createdTime=Wed Nov 23 13:27:04 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103222, encodeId=82cf2103222d9, content=这本期刊信誉怎么样？业内认可度高吗？也属于老牌期刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34af8129929, createdName=ms4000001357719360, createdTime=Tue Nov 29 01:08:38 CST 2022, time=2022-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1222433, encodeId=3b9a1222433c8, content=审稿速度:6.0 偏重的研究方向：肿瘤 经验分享：一审 Revision Received 20th Feb 22 Waiting for Revision 25th Jan 22 Decision made 25th Jan 22 Under consideration 23rd Jan 22 Under review 3rd Dec 21 Under consideration 26th Nov 21 Author Approved Converted Files 26th Nov 21 Under submission 26th Nov 21 二审 Revision Received 13th Apr 22 Waiting for Revision 13th Apr 22 Decision made 13th Apr 22 Under consideration 31st Mar 22 Under review 25th Feb 22 Under consideration 24th Feb 22 Author Approved Converted Files 24th Feb 22 Under submission 20th Feb 22 作者排序修改 Decision made 26th Apr 22 Under consideration 14th Apr 22 Author Approved Converted Files 14th Apr 22 Under submission 13th Apr 22 总体来说非常慢，外审2月，着急毕业不推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=20851720534, createdName=淡霜凝眉, createdTime=Wed May 25 21:34:50 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209414, encodeId=8599120941464, content=请问各位大神需要原始数据吗? 需要提前准备什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1495413486, createdName=ms9000001367840543, createdTime=Thu Apr 07 23:27:33 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008695, encodeId=17f31008695d0, content=under review两个月，结果只回来一个审稿人的意见，就把我给拒了.这也太离谱了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Tue Aug 17 14:15:09 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975008, encodeId=6b4c9e500850, content=6月4号投稿后under consideration，6月15号变成under review。各位的审稿周期有多长啊，给我点心理准备。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Sat Jun 19 23:49:26 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801630, encodeId=c5ed80163090, content=审稿速度:3.0 偏重的研究方向：肿瘤转移;基础研究 经验分享：今天刚接收了一篇，去年12月份投稿，一审近三个月，两个审稿人，其中一个特别专业，提出了研究的核心问题。补实验两个半月，二审半个月，accept in principle，一个审稿人建议修改一个专业术语用词，三天后投回，27天后正式接受。总的来说这个杂志周期稍长，老牌期刊，审稿人比较专业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62ac1651094, createdName=wyf7331, createdTime=Tue Jul 07 16:35:18 CST 2020, time=2020-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799929, encodeId=8b55e99929af, content=审稿速度:3.0 经验分享：under review送审后变回under consideration12天了，应该是回到编辑手里了吧？一直没有做出决定，好焦急。一审70多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48b43066690, createdName=11718250, createdTime=Fri Jun 26 14:28:53 CST 2020, time=2020-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591465, encodeId=6901591465bf, content=一个月 189****1270haoliangdut 2020-02-27 发表:: 谢谢回答，请问您返修后多长时间接收的呀？189****1270haoliangdut 2020-02-27 00:00:00 发表: 谢谢回答，请问您返修后多长时间接收的呀？, beContent=189****1270haoliangdut 2020-02-27 发表:: 谢谢回答，请问您返修后多长时间接收的呀？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41be2522582, createdName=124e1d81m04暂无昵称, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=)]

2023-05-25 阿曾曾曾曾来自上海

收回顾性文章吗.......

68 0

[GetPortalCommentsPageByObjectIdResponse(id=2139001, encodeId=cb7a213900173, content=收回顾性文章吗......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Thu May 25 15:37:45 CST 2023, time=2023-05-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2102172, encodeId=288621021e22a, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤药理 经验分享：太太太太慢了，一审半年，补实验两个月，又等了四个月，最后拒稿！慎投！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3f785469539, createdName=ms2000001925534900, createdTime=Wed Nov 23 13:27:04 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103222, encodeId=82cf2103222d9, content=这本期刊信誉怎么样？业内认可度高吗？也属于老牌期刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34af8129929, createdName=ms4000001357719360, createdTime=Tue Nov 29 01:08:38 CST 2022, time=2022-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1222433, encodeId=3b9a1222433c8, content=审稿速度:6.0 偏重的研究方向：肿瘤 经验分享：一审 Revision Received 20th Feb 22 Waiting for Revision 25th Jan 22 Decision made 25th Jan 22 Under consideration 23rd Jan 22 Under review 3rd Dec 21 Under consideration 26th Nov 21 Author Approved Converted Files 26th Nov 21 Under submission 26th Nov 21 二审 Revision Received 13th Apr 22 Waiting for Revision 13th Apr 22 Decision made 13th Apr 22 Under consideration 31st Mar 22 Under review 25th Feb 22 Under consideration 24th Feb 22 Author Approved Converted Files 24th Feb 22 Under submission 20th Feb 22 作者排序修改 Decision made 26th Apr 22 Under consideration 14th Apr 22 Author Approved Converted Files 14th Apr 22 Under submission 13th Apr 22 总体来说非常慢，外审2月，着急毕业不推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=20851720534, createdName=淡霜凝眉, createdTime=Wed May 25 21:34:50 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209414, encodeId=8599120941464, content=请问各位大神需要原始数据吗? 需要提前准备什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1495413486, createdName=ms9000001367840543, createdTime=Thu Apr 07 23:27:33 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008695, encodeId=17f31008695d0, content=under review两个月，结果只回来一个审稿人的意见，就把我给拒了.这也太离谱了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Tue Aug 17 14:15:09 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975008, encodeId=6b4c9e500850, content=6月4号投稿后under consideration，6月15号变成under review。各位的审稿周期有多长啊，给我点心理准备。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Sat Jun 19 23:49:26 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801630, encodeId=c5ed80163090, content=审稿速度:3.0 偏重的研究方向：肿瘤转移;基础研究 经验分享：今天刚接收了一篇，去年12月份投稿，一审近三个月，两个审稿人，其中一个特别专业，提出了研究的核心问题。补实验两个半月，二审半个月，accept in principle，一个审稿人建议修改一个专业术语用词，三天后投回，27天后正式接受。总的来说这个杂志周期稍长，老牌期刊，审稿人比较专业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62ac1651094, createdName=wyf7331, createdTime=Tue Jul 07 16:35:18 CST 2020, time=2020-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799929, encodeId=8b55e99929af, content=审稿速度:3.0 经验分享：under review送审后变回under consideration12天了，应该是回到编辑手里了吧？一直没有做出决定，好焦急。一审70多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48b43066690, createdName=11718250, createdTime=Fri Jun 26 14:28:53 CST 2020, time=2020-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591465, encodeId=6901591465bf, content=一个月 189****1270haoliangdut 2020-02-27 发表:: 谢谢回答，请问您返修后多长时间接收的呀？189****1270haoliangdut 2020-02-27 00:00:00 发表: 谢谢回答，请问您返修后多长时间接收的呀？, beContent=189****1270haoliangdut 2020-02-27 发表:: 谢谢回答，请问您返修后多长时间接收的呀？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41be2522582, createdName=124e1d81m04暂无昵称, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=)]

2022-11-23 ms2000001925534900

审稿速度:12.0 | 投稿命中率:5.0
偏重的研究方向：肿瘤药理
经验分享：太太太太慢了，一审半年，补实验两个月，又等了四个月，最后拒稿！慎投！！

65 0

[GetPortalCommentsPageByObjectIdResponse(id=2139001, encodeId=cb7a213900173, content=收回顾性文章吗......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Thu May 25 15:37:45 CST 2023, time=2023-05-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2102172, encodeId=288621021e22a, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤药理 经验分享：太太太太慢了，一审半年，补实验两个月，又等了四个月，最后拒稿！慎投！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3f785469539, createdName=ms2000001925534900, createdTime=Wed Nov 23 13:27:04 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103222, encodeId=82cf2103222d9, content=这本期刊信誉怎么样？业内认可度高吗？也属于老牌期刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34af8129929, createdName=ms4000001357719360, createdTime=Tue Nov 29 01:08:38 CST 2022, time=2022-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1222433, encodeId=3b9a1222433c8, content=审稿速度:6.0 偏重的研究方向：肿瘤 经验分享：一审 Revision Received 20th Feb 22 Waiting for Revision 25th Jan 22 Decision made 25th Jan 22 Under consideration 23rd Jan 22 Under review 3rd Dec 21 Under consideration 26th Nov 21 Author Approved Converted Files 26th Nov 21 Under submission 26th Nov 21 二审 Revision Received 13th Apr 22 Waiting for Revision 13th Apr 22 Decision made 13th Apr 22 Under consideration 31st Mar 22 Under review 25th Feb 22 Under consideration 24th Feb 22 Author Approved Converted Files 24th Feb 22 Under submission 20th Feb 22 作者排序修改 Decision made 26th Apr 22 Under consideration 14th Apr 22 Author Approved Converted Files 14th Apr 22 Under submission 13th Apr 22 总体来说非常慢，外审2月，着急毕业不推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=20851720534, createdName=淡霜凝眉, createdTime=Wed May 25 21:34:50 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209414, encodeId=8599120941464, content=请问各位大神需要原始数据吗? 需要提前准备什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1495413486, createdName=ms9000001367840543, createdTime=Thu Apr 07 23:27:33 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008695, encodeId=17f31008695d0, content=under review两个月，结果只回来一个审稿人的意见，就把我给拒了.这也太离谱了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Tue Aug 17 14:15:09 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975008, encodeId=6b4c9e500850, content=6月4号投稿后under consideration，6月15号变成under review。各位的审稿周期有多长啊，给我点心理准备。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Sat Jun 19 23:49:26 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801630, encodeId=c5ed80163090, content=审稿速度:3.0 偏重的研究方向：肿瘤转移;基础研究 经验分享：今天刚接收了一篇，去年12月份投稿，一审近三个月，两个审稿人，其中一个特别专业，提出了研究的核心问题。补实验两个半月，二审半个月，accept in principle，一个审稿人建议修改一个专业术语用词，三天后投回，27天后正式接受。总的来说这个杂志周期稍长，老牌期刊，审稿人比较专业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62ac1651094, createdName=wyf7331, createdTime=Tue Jul 07 16:35:18 CST 2020, time=2020-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799929, encodeId=8b55e99929af, content=审稿速度:3.0 经验分享：under review送审后变回under consideration12天了，应该是回到编辑手里了吧？一直没有做出决定，好焦急。一审70多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48b43066690, createdName=11718250, createdTime=Fri Jun 26 14:28:53 CST 2020, time=2020-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591465, encodeId=6901591465bf, content=一个月 189****1270haoliangdut 2020-02-27 发表:: 谢谢回答，请问您返修后多长时间接收的呀？189****1270haoliangdut 2020-02-27 00:00:00 发表: 谢谢回答，请问您返修后多长时间接收的呀？, beContent=189****1270haoliangdut 2020-02-27 发表:: 谢谢回答，请问您返修后多长时间接收的呀？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41be2522582, createdName=124e1d81m04暂无昵称, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=)]

2022-11-29 ms4000001357719360 来自河南省

这本期刊信誉怎么样？业内认可度高吗？也属于老牌期刊了

55 0

[GetPortalCommentsPageByObjectIdResponse(id=2139001, encodeId=cb7a213900173, content=收回顾性文章吗......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Thu May 25 15:37:45 CST 2023, time=2023-05-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2102172, encodeId=288621021e22a, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤药理 经验分享：太太太太慢了，一审半年，补实验两个月，又等了四个月，最后拒稿！慎投！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3f785469539, createdName=ms2000001925534900, createdTime=Wed Nov 23 13:27:04 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103222, encodeId=82cf2103222d9, content=这本期刊信誉怎么样？业内认可度高吗？也属于老牌期刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34af8129929, createdName=ms4000001357719360, createdTime=Tue Nov 29 01:08:38 CST 2022, time=2022-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1222433, encodeId=3b9a1222433c8, content=审稿速度:6.0 偏重的研究方向：肿瘤 经验分享：一审 Revision Received 20th Feb 22 Waiting for Revision 25th Jan 22 Decision made 25th Jan 22 Under consideration 23rd Jan 22 Under review 3rd Dec 21 Under consideration 26th Nov 21 Author Approved Converted Files 26th Nov 21 Under submission 26th Nov 21 二审 Revision Received 13th Apr 22 Waiting for Revision 13th Apr 22 Decision made 13th Apr 22 Under consideration 31st Mar 22 Under review 25th Feb 22 Under consideration 24th Feb 22 Author Approved Converted Files 24th Feb 22 Under submission 20th Feb 22 作者排序修改 Decision made 26th Apr 22 Under consideration 14th Apr 22 Author Approved Converted Files 14th Apr 22 Under submission 13th Apr 22 总体来说非常慢，外审2月，着急毕业不推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=20851720534, createdName=淡霜凝眉, createdTime=Wed May 25 21:34:50 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209414, encodeId=8599120941464, content=请问各位大神需要原始数据吗? 需要提前准备什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1495413486, createdName=ms9000001367840543, createdTime=Thu Apr 07 23:27:33 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008695, encodeId=17f31008695d0, content=under review两个月，结果只回来一个审稿人的意见，就把我给拒了.这也太离谱了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Tue Aug 17 14:15:09 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975008, encodeId=6b4c9e500850, content=6月4号投稿后under consideration，6月15号变成under review。各位的审稿周期有多长啊，给我点心理准备。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Sat Jun 19 23:49:26 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801630, encodeId=c5ed80163090, content=审稿速度:3.0 偏重的研究方向：肿瘤转移;基础研究 经验分享：今天刚接收了一篇，去年12月份投稿，一审近三个月，两个审稿人，其中一个特别专业，提出了研究的核心问题。补实验两个半月，二审半个月，accept in principle，一个审稿人建议修改一个专业术语用词，三天后投回，27天后正式接受。总的来说这个杂志周期稍长，老牌期刊，审稿人比较专业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62ac1651094, createdName=wyf7331, createdTime=Tue Jul 07 16:35:18 CST 2020, time=2020-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799929, encodeId=8b55e99929af, content=审稿速度:3.0 经验分享：under review送审后变回under consideration12天了，应该是回到编辑手里了吧？一直没有做出决定，好焦急。一审70多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48b43066690, createdName=11718250, createdTime=Fri Jun 26 14:28:53 CST 2020, time=2020-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591465, encodeId=6901591465bf, content=一个月 189****1270haoliangdut 2020-02-27 发表:: 谢谢回答，请问您返修后多长时间接收的呀？189****1270haoliangdut 2020-02-27 00:00:00 发表: 谢谢回答，请问您返修后多长时间接收的呀？, beContent=189****1270haoliangdut 2020-02-27 发表:: 谢谢回答，请问您返修后多长时间接收的呀？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41be2522582, createdName=124e1d81m04暂无昵称, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=)]

2022-05-25 淡霜凝眉

审稿速度:6.0
偏重的研究方向：肿瘤
经验分享：一审
Revision Received 20th Feb 22
Waiting for Revision 25th Jan 22
Decision made 25th Jan 22
Under consideration 23rd Jan 22
Under review 3rd Dec 21
Under consideration 26th Nov 21
Author Approved Converted Files 26th Nov 21
Under submission 26th Nov 21
二审
Revision Received 13th Apr 22
Waiting for Revision 13th Apr 22
Decision made 13th Apr 22
Under consideration 31st Mar 22
Under review 25th Feb 22
Under consideration 24th Feb 22
Author Approved Converted Files 24th Feb 22
Under submission 20th Feb 22
作者排序修改
Decision made 26th Apr 22
Under consideration 14th Apr 22
Author Approved Converted Files 14th Apr 22
Under submission 13th Apr 22

总体来说非常慢，外审2月，着急毕业不推荐

66 0

[GetPortalCommentsPageByObjectIdResponse(id=2139001, encodeId=cb7a213900173, content=收回顾性文章吗......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Thu May 25 15:37:45 CST 2023, time=2023-05-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2102172, encodeId=288621021e22a, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤药理 经验分享：太太太太慢了，一审半年，补实验两个月，又等了四个月，最后拒稿！慎投！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3f785469539, createdName=ms2000001925534900, createdTime=Wed Nov 23 13:27:04 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103222, encodeId=82cf2103222d9, content=这本期刊信誉怎么样？业内认可度高吗？也属于老牌期刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34af8129929, createdName=ms4000001357719360, createdTime=Tue Nov 29 01:08:38 CST 2022, time=2022-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1222433, encodeId=3b9a1222433c8, content=审稿速度:6.0 偏重的研究方向：肿瘤 经验分享：一审 Revision Received 20th Feb 22 Waiting for Revision 25th Jan 22 Decision made 25th Jan 22 Under consideration 23rd Jan 22 Under review 3rd Dec 21 Under consideration 26th Nov 21 Author Approved Converted Files 26th Nov 21 Under submission 26th Nov 21 二审 Revision Received 13th Apr 22 Waiting for Revision 13th Apr 22 Decision made 13th Apr 22 Under consideration 31st Mar 22 Under review 25th Feb 22 Under consideration 24th Feb 22 Author Approved Converted Files 24th Feb 22 Under submission 20th Feb 22 作者排序修改 Decision made 26th Apr 22 Under consideration 14th Apr 22 Author Approved Converted Files 14th Apr 22 Under submission 13th Apr 22 总体来说非常慢，外审2月，着急毕业不推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=20851720534, createdName=淡霜凝眉, createdTime=Wed May 25 21:34:50 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209414, encodeId=8599120941464, content=请问各位大神需要原始数据吗? 需要提前准备什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1495413486, createdName=ms9000001367840543, createdTime=Thu Apr 07 23:27:33 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008695, encodeId=17f31008695d0, content=under review两个月，结果只回来一个审稿人的意见，就把我给拒了.这也太离谱了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Tue Aug 17 14:15:09 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975008, encodeId=6b4c9e500850, content=6月4号投稿后under consideration，6月15号变成under review。各位的审稿周期有多长啊，给我点心理准备。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Sat Jun 19 23:49:26 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801630, encodeId=c5ed80163090, content=审稿速度:3.0 偏重的研究方向：肿瘤转移;基础研究 经验分享：今天刚接收了一篇，去年12月份投稿，一审近三个月，两个审稿人，其中一个特别专业，提出了研究的核心问题。补实验两个半月，二审半个月，accept in principle，一个审稿人建议修改一个专业术语用词，三天后投回，27天后正式接受。总的来说这个杂志周期稍长，老牌期刊，审稿人比较专业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62ac1651094, createdName=wyf7331, createdTime=Tue Jul 07 16:35:18 CST 2020, time=2020-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799929, encodeId=8b55e99929af, content=审稿速度:3.0 经验分享：under review送审后变回under consideration12天了，应该是回到编辑手里了吧？一直没有做出决定，好焦急。一审70多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48b43066690, createdName=11718250, createdTime=Fri Jun 26 14:28:53 CST 2020, time=2020-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591465, encodeId=6901591465bf, content=一个月 189****1270haoliangdut 2020-02-27 发表:: 谢谢回答，请问您返修后多长时间接收的呀？189****1270haoliangdut 2020-02-27 00:00:00 发表: 谢谢回答，请问您返修后多长时间接收的呀？, beContent=189****1270haoliangdut 2020-02-27 发表:: 谢谢回答，请问您返修后多长时间接收的呀？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41be2522582, createdName=124e1d81m04暂无昵称, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=)]

2022-04-07 ms9000001367840543

请问各位大神需要原始数据吗? 需要提前准备什么?

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2139001, encodeId=cb7a213900173, content=收回顾性文章吗......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Thu May 25 15:37:45 CST 2023, time=2023-05-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2102172, encodeId=288621021e22a, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤药理 经验分享：太太太太慢了，一审半年，补实验两个月，又等了四个月，最后拒稿！慎投！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3f785469539, createdName=ms2000001925534900, createdTime=Wed Nov 23 13:27:04 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103222, encodeId=82cf2103222d9, content=这本期刊信誉怎么样？业内认可度高吗？也属于老牌期刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34af8129929, createdName=ms4000001357719360, createdTime=Tue Nov 29 01:08:38 CST 2022, time=2022-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1222433, encodeId=3b9a1222433c8, content=审稿速度:6.0 偏重的研究方向：肿瘤 经验分享：一审 Revision Received 20th Feb 22 Waiting for Revision 25th Jan 22 Decision made 25th Jan 22 Under consideration 23rd Jan 22 Under review 3rd Dec 21 Under consideration 26th Nov 21 Author Approved Converted Files 26th Nov 21 Under submission 26th Nov 21 二审 Revision Received 13th Apr 22 Waiting for Revision 13th Apr 22 Decision made 13th Apr 22 Under consideration 31st Mar 22 Under review 25th Feb 22 Under consideration 24th Feb 22 Author Approved Converted Files 24th Feb 22 Under submission 20th Feb 22 作者排序修改 Decision made 26th Apr 22 Under consideration 14th Apr 22 Author Approved Converted Files 14th Apr 22 Under submission 13th Apr 22 总体来说非常慢，外审2月，着急毕业不推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=20851720534, createdName=淡霜凝眉, createdTime=Wed May 25 21:34:50 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209414, encodeId=8599120941464, content=请问各位大神需要原始数据吗? 需要提前准备什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1495413486, createdName=ms9000001367840543, createdTime=Thu Apr 07 23:27:33 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008695, encodeId=17f31008695d0, content=under review两个月，结果只回来一个审稿人的意见，就把我给拒了.这也太离谱了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Tue Aug 17 14:15:09 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975008, encodeId=6b4c9e500850, content=6月4号投稿后under consideration，6月15号变成under review。各位的审稿周期有多长啊，给我点心理准备。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Sat Jun 19 23:49:26 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801630, encodeId=c5ed80163090, content=审稿速度:3.0 偏重的研究方向：肿瘤转移;基础研究 经验分享：今天刚接收了一篇，去年12月份投稿，一审近三个月，两个审稿人，其中一个特别专业，提出了研究的核心问题。补实验两个半月，二审半个月，accept in principle，一个审稿人建议修改一个专业术语用词，三天后投回，27天后正式接受。总的来说这个杂志周期稍长，老牌期刊，审稿人比较专业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62ac1651094, createdName=wyf7331, createdTime=Tue Jul 07 16:35:18 CST 2020, time=2020-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799929, encodeId=8b55e99929af, content=审稿速度:3.0 经验分享：under review送审后变回under consideration12天了，应该是回到编辑手里了吧？一直没有做出决定，好焦急。一审70多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48b43066690, createdName=11718250, createdTime=Fri Jun 26 14:28:53 CST 2020, time=2020-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591465, encodeId=6901591465bf, content=一个月 189****1270haoliangdut 2020-02-27 发表:: 谢谢回答，请问您返修后多长时间接收的呀？189****1270haoliangdut 2020-02-27 00:00:00 发表: 谢谢回答，请问您返修后多长时间接收的呀？, beContent=189****1270haoliangdut 2020-02-27 发表:: 谢谢回答，请问您返修后多长时间接收的呀？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41be2522582, createdName=124e1d81m04暂无昵称, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=)]

2021-08-17 H·D·E

under review两个月，结果只回来一个审稿人的意见，就把我给拒了.这也太离谱了

146 0

[GetPortalCommentsPageByObjectIdResponse(id=2139001, encodeId=cb7a213900173, content=收回顾性文章吗......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Thu May 25 15:37:45 CST 2023, time=2023-05-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2102172, encodeId=288621021e22a, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤药理 经验分享：太太太太慢了，一审半年，补实验两个月，又等了四个月，最后拒稿！慎投！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3f785469539, createdName=ms2000001925534900, createdTime=Wed Nov 23 13:27:04 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103222, encodeId=82cf2103222d9, content=这本期刊信誉怎么样？业内认可度高吗？也属于老牌期刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34af8129929, createdName=ms4000001357719360, createdTime=Tue Nov 29 01:08:38 CST 2022, time=2022-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1222433, encodeId=3b9a1222433c8, content=审稿速度:6.0 偏重的研究方向：肿瘤 经验分享：一审 Revision Received 20th Feb 22 Waiting for Revision 25th Jan 22 Decision made 25th Jan 22 Under consideration 23rd Jan 22 Under review 3rd Dec 21 Under consideration 26th Nov 21 Author Approved Converted Files 26th Nov 21 Under submission 26th Nov 21 二审 Revision Received 13th Apr 22 Waiting for Revision 13th Apr 22 Decision made 13th Apr 22 Under consideration 31st Mar 22 Under review 25th Feb 22 Under consideration 24th Feb 22 Author Approved Converted Files 24th Feb 22 Under submission 20th Feb 22 作者排序修改 Decision made 26th Apr 22 Under consideration 14th Apr 22 Author Approved Converted Files 14th Apr 22 Under submission 13th Apr 22 总体来说非常慢，外审2月，着急毕业不推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=20851720534, createdName=淡霜凝眉, createdTime=Wed May 25 21:34:50 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209414, encodeId=8599120941464, content=请问各位大神需要原始数据吗? 需要提前准备什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1495413486, createdName=ms9000001367840543, createdTime=Thu Apr 07 23:27:33 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008695, encodeId=17f31008695d0, content=under review两个月，结果只回来一个审稿人的意见，就把我给拒了.这也太离谱了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Tue Aug 17 14:15:09 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975008, encodeId=6b4c9e500850, content=6月4号投稿后under consideration，6月15号变成under review。各位的审稿周期有多长啊，给我点心理准备。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Sat Jun 19 23:49:26 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801630, encodeId=c5ed80163090, content=审稿速度:3.0 偏重的研究方向：肿瘤转移;基础研究 经验分享：今天刚接收了一篇，去年12月份投稿，一审近三个月，两个审稿人，其中一个特别专业，提出了研究的核心问题。补实验两个半月，二审半个月，accept in principle，一个审稿人建议修改一个专业术语用词，三天后投回，27天后正式接受。总的来说这个杂志周期稍长，老牌期刊，审稿人比较专业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62ac1651094, createdName=wyf7331, createdTime=Tue Jul 07 16:35:18 CST 2020, time=2020-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799929, encodeId=8b55e99929af, content=审稿速度:3.0 经验分享：under review送审后变回under consideration12天了，应该是回到编辑手里了吧？一直没有做出决定，好焦急。一审70多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48b43066690, createdName=11718250, createdTime=Fri Jun 26 14:28:53 CST 2020, time=2020-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591465, encodeId=6901591465bf, content=一个月 189****1270haoliangdut 2020-02-27 发表:: 谢谢回答，请问您返修后多长时间接收的呀？189****1270haoliangdut 2020-02-27 00:00:00 发表: 谢谢回答，请问您返修后多长时间接收的呀？, beContent=189****1270haoliangdut 2020-02-27 发表:: 谢谢回答，请问您返修后多长时间接收的呀？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41be2522582, createdName=124e1d81m04暂无昵称, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=)]

2021-06-19 H·D·E

6月4号投稿后under consideration，6月15号变成under review。各位的审稿周期有多长啊，给我点心理准备。

157 0

[GetPortalCommentsPageByObjectIdResponse(id=2139001, encodeId=cb7a213900173, content=收回顾性文章吗......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Thu May 25 15:37:45 CST 2023, time=2023-05-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2102172, encodeId=288621021e22a, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤药理 经验分享：太太太太慢了，一审半年，补实验两个月，又等了四个月，最后拒稿！慎投！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3f785469539, createdName=ms2000001925534900, createdTime=Wed Nov 23 13:27:04 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103222, encodeId=82cf2103222d9, content=这本期刊信誉怎么样？业内认可度高吗？也属于老牌期刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34af8129929, createdName=ms4000001357719360, createdTime=Tue Nov 29 01:08:38 CST 2022, time=2022-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1222433, encodeId=3b9a1222433c8, content=审稿速度:6.0 偏重的研究方向：肿瘤 经验分享：一审 Revision Received 20th Feb 22 Waiting for Revision 25th Jan 22 Decision made 25th Jan 22 Under consideration 23rd Jan 22 Under review 3rd Dec 21 Under consideration 26th Nov 21 Author Approved Converted Files 26th Nov 21 Under submission 26th Nov 21 二审 Revision Received 13th Apr 22 Waiting for Revision 13th Apr 22 Decision made 13th Apr 22 Under consideration 31st Mar 22 Under review 25th Feb 22 Under consideration 24th Feb 22 Author Approved Converted Files 24th Feb 22 Under submission 20th Feb 22 作者排序修改 Decision made 26th Apr 22 Under consideration 14th Apr 22 Author Approved Converted Files 14th Apr 22 Under submission 13th Apr 22 总体来说非常慢，外审2月，着急毕业不推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=20851720534, createdName=淡霜凝眉, createdTime=Wed May 25 21:34:50 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209414, encodeId=8599120941464, content=请问各位大神需要原始数据吗? 需要提前准备什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1495413486, createdName=ms9000001367840543, createdTime=Thu Apr 07 23:27:33 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008695, encodeId=17f31008695d0, content=under review两个月，结果只回来一个审稿人的意见，就把我给拒了.这也太离谱了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Tue Aug 17 14:15:09 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975008, encodeId=6b4c9e500850, content=6月4号投稿后under consideration，6月15号变成under review。各位的审稿周期有多长啊，给我点心理准备。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Sat Jun 19 23:49:26 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801630, encodeId=c5ed80163090, content=审稿速度:3.0 偏重的研究方向：肿瘤转移;基础研究 经验分享：今天刚接收了一篇，去年12月份投稿，一审近三个月，两个审稿人，其中一个特别专业，提出了研究的核心问题。补实验两个半月，二审半个月，accept in principle，一个审稿人建议修改一个专业术语用词，三天后投回，27天后正式接受。总的来说这个杂志周期稍长，老牌期刊，审稿人比较专业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62ac1651094, createdName=wyf7331, createdTime=Tue Jul 07 16:35:18 CST 2020, time=2020-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799929, encodeId=8b55e99929af, content=审稿速度:3.0 经验分享：under review送审后变回under consideration12天了，应该是回到编辑手里了吧？一直没有做出决定，好焦急。一审70多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48b43066690, createdName=11718250, createdTime=Fri Jun 26 14:28:53 CST 2020, time=2020-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591465, encodeId=6901591465bf, content=一个月 189****1270haoliangdut 2020-02-27 发表:: 谢谢回答，请问您返修后多长时间接收的呀？189****1270haoliangdut 2020-02-27 00:00:00 发表: 谢谢回答，请问您返修后多长时间接收的呀？, beContent=189****1270haoliangdut 2020-02-27 发表:: 谢谢回答，请问您返修后多长时间接收的呀？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41be2522582, createdName=124e1d81m04暂无昵称, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=)]

2020-07-07 wyf7331

审稿速度:3.0
偏重的研究方向：肿瘤转移;基础研究
经验分享：今天刚接收了一篇，去年12月份投稿，一审近三个月，两个审稿人，其中一个特别专业，提出了研究的核心问题。补实验两个半月，二审半个月，accept in principle，一个审稿人建议修改一个专业术语用词，三天后投回，27天后正式接受。总的来说这个杂志周期稍长，老牌期刊，审稿人比较专业。

240 0

[GetPortalCommentsPageByObjectIdResponse(id=2139001, encodeId=cb7a213900173, content=收回顾性文章吗......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Thu May 25 15:37:45 CST 2023, time=2023-05-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2102172, encodeId=288621021e22a, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤药理 经验分享：太太太太慢了，一审半年，补实验两个月，又等了四个月，最后拒稿！慎投！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3f785469539, createdName=ms2000001925534900, createdTime=Wed Nov 23 13:27:04 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103222, encodeId=82cf2103222d9, content=这本期刊信誉怎么样？业内认可度高吗？也属于老牌期刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34af8129929, createdName=ms4000001357719360, createdTime=Tue Nov 29 01:08:38 CST 2022, time=2022-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1222433, encodeId=3b9a1222433c8, content=审稿速度:6.0 偏重的研究方向：肿瘤 经验分享：一审 Revision Received 20th Feb 22 Waiting for Revision 25th Jan 22 Decision made 25th Jan 22 Under consideration 23rd Jan 22 Under review 3rd Dec 21 Under consideration 26th Nov 21 Author Approved Converted Files 26th Nov 21 Under submission 26th Nov 21 二审 Revision Received 13th Apr 22 Waiting for Revision 13th Apr 22 Decision made 13th Apr 22 Under consideration 31st Mar 22 Under review 25th Feb 22 Under consideration 24th Feb 22 Author Approved Converted Files 24th Feb 22 Under submission 20th Feb 22 作者排序修改 Decision made 26th Apr 22 Under consideration 14th Apr 22 Author Approved Converted Files 14th Apr 22 Under submission 13th Apr 22 总体来说非常慢，外审2月，着急毕业不推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=20851720534, createdName=淡霜凝眉, createdTime=Wed May 25 21:34:50 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209414, encodeId=8599120941464, content=请问各位大神需要原始数据吗? 需要提前准备什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1495413486, createdName=ms9000001367840543, createdTime=Thu Apr 07 23:27:33 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008695, encodeId=17f31008695d0, content=under review两个月，结果只回来一个审稿人的意见，就把我给拒了.这也太离谱了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Tue Aug 17 14:15:09 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975008, encodeId=6b4c9e500850, content=6月4号投稿后under consideration，6月15号变成under review。各位的审稿周期有多长啊，给我点心理准备。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Sat Jun 19 23:49:26 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801630, encodeId=c5ed80163090, content=审稿速度:3.0 偏重的研究方向：肿瘤转移;基础研究 经验分享：今天刚接收了一篇，去年12月份投稿，一审近三个月，两个审稿人，其中一个特别专业，提出了研究的核心问题。补实验两个半月，二审半个月，accept in principle，一个审稿人建议修改一个专业术语用词，三天后投回，27天后正式接受。总的来说这个杂志周期稍长，老牌期刊，审稿人比较专业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62ac1651094, createdName=wyf7331, createdTime=Tue Jul 07 16:35:18 CST 2020, time=2020-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799929, encodeId=8b55e99929af, content=审稿速度:3.0 经验分享：under review送审后变回under consideration12天了，应该是回到编辑手里了吧？一直没有做出决定，好焦急。一审70多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48b43066690, createdName=11718250, createdTime=Fri Jun 26 14:28:53 CST 2020, time=2020-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591465, encodeId=6901591465bf, content=一个月 189****1270haoliangdut 2020-02-27 发表:: 谢谢回答，请问您返修后多长时间接收的呀？189****1270haoliangdut 2020-02-27 00:00:00 发表: 谢谢回答，请问您返修后多长时间接收的呀？, beContent=189****1270haoliangdut 2020-02-27 发表:: 谢谢回答，请问您返修后多长时间接收的呀？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41be2522582, createdName=124e1d81m04暂无昵称, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=)]

2020-06-26 11718250

审稿速度:3.0
经验分享：under review送审后变回under consideration12天了，应该是回到编辑手里了吧？一直没有做出决定，好焦急。一审70多天了

234 0

[GetPortalCommentsPageByObjectIdResponse(id=2139001, encodeId=cb7a213900173, content=收回顾性文章吗......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Thu May 25 15:37:45 CST 2023, time=2023-05-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2102172, encodeId=288621021e22a, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤药理 经验分享：太太太太慢了，一审半年，补实验两个月，又等了四个月，最后拒稿！慎投！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3f785469539, createdName=ms2000001925534900, createdTime=Wed Nov 23 13:27:04 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103222, encodeId=82cf2103222d9, content=这本期刊信誉怎么样？业内认可度高吗？也属于老牌期刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34af8129929, createdName=ms4000001357719360, createdTime=Tue Nov 29 01:08:38 CST 2022, time=2022-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1222433, encodeId=3b9a1222433c8, content=审稿速度:6.0 偏重的研究方向：肿瘤 经验分享：一审 Revision Received 20th Feb 22 Waiting for Revision 25th Jan 22 Decision made 25th Jan 22 Under consideration 23rd Jan 22 Under review 3rd Dec 21 Under consideration 26th Nov 21 Author Approved Converted Files 26th Nov 21 Under submission 26th Nov 21 二审 Revision Received 13th Apr 22 Waiting for Revision 13th Apr 22 Decision made 13th Apr 22 Under consideration 31st Mar 22 Under review 25th Feb 22 Under consideration 24th Feb 22 Author Approved Converted Files 24th Feb 22 Under submission 20th Feb 22 作者排序修改 Decision made 26th Apr 22 Under consideration 14th Apr 22 Author Approved Converted Files 14th Apr 22 Under submission 13th Apr 22 总体来说非常慢，外审2月，着急毕业不推荐, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=20851720534, createdName=淡霜凝眉, createdTime=Wed May 25 21:34:50 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209414, encodeId=8599120941464, content=请问各位大神需要原始数据吗? 需要提前准备什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1495413486, createdName=ms9000001367840543, createdTime=Thu Apr 07 23:27:33 CST 2022, time=2022-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008695, encodeId=17f31008695d0, content=under review两个月，结果只回来一个审稿人的意见，就把我给拒了.这也太离谱了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Tue Aug 17 14:15:09 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975008, encodeId=6b4c9e500850, content=6月4号投稿后under consideration，6月15号变成under review。各位的审稿周期有多长啊，给我点心理准备。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Sat Jun 19 23:49:26 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801630, encodeId=c5ed80163090, content=审稿速度:3.0 偏重的研究方向：肿瘤转移;基础研究 经验分享：今天刚接收了一篇，去年12月份投稿，一审近三个月，两个审稿人，其中一个特别专业，提出了研究的核心问题。补实验两个半月，二审半个月，accept in principle，一个审稿人建议修改一个专业术语用词，三天后投回，27天后正式接受。总的来说这个杂志周期稍长，老牌期刊，审稿人比较专业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62ac1651094, createdName=wyf7331, createdTime=Tue Jul 07 16:35:18 CST 2020, time=2020-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799929, encodeId=8b55e99929af, content=审稿速度:3.0 经验分享：under review送审后变回under consideration12天了，应该是回到编辑手里了吧？一直没有做出决定，好焦急。一审70多天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48b43066690, createdName=11718250, createdTime=Fri Jun 26 14:28:53 CST 2020, time=2020-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591465, encodeId=6901591465bf, content=一个月 189****1270haoliangdut 2020-02-27 发表:: 谢谢回答，请问您返修后多长时间接收的呀？189****1270haoliangdut 2020-02-27 00:00:00 发表: 谢谢回答，请问您返修后多长时间接收的呀？, beContent=189****1270haoliangdut 2020-02-27 发表:: 谢谢回答，请问您返修后多长时间接收的呀？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41be2522582, createdName=124e1d81m04暂无昵称, createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=)]

2020-05-21 124e1d81m04暂无昵称

一个月 189****1270haoliangdut 2020-02-27 发表::
谢谢回答，请问您返修后多长时间接收的呀？189****1270haoliangdut 2020-02-27 00:00:00 发表:
谢谢回答，请问您返修后多长时间接收的呀？

189****1270haoliangdut 2020-02-27 发表:: 谢谢回答，请问您返修后多长时间接收的呀？

193 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务